2021/09/24

Psychiatry and the Potential of Digital Tools(Series #3)

Current Status of Digital Therapeutics for Mild Cognitive Impairment

Dimentia, Clinical Doctor, Digital Therapeutics (DTx), Disease management and Patient monitoring

Dr. Y

System Development and Market Expansion from Diagnosis to Treatment

It is well known that Japan is becoming a super-aging society, but the same is true for other developed countries. In the U.S., for example, there are currently 5.8 million patients with Alzheimer's disease (AD), and this number is estimated to increase to 13.8 million by 2050. Pre-consultation Screening with Digital Therapeutics is needed (see the previous article, “Digital Screening for Cognitive Impairment”) all the more that the percentage of patients reaching for medical care is small. As the need for this technology increases year by year, it also means that the market for dementia diagnosis and treatment will expand, and many people are probably thinking of ways to monetize it.

In the U.S., start-up research is taking off, backed by huge research funding. For example, neuroFit, a San Francisco-based company, is collaborating with the National Institutes of Health (NIH) on a study to screen for mild cognitive impairment (MCI) based on eye movements.

(Continue to the next)


The information contained in this article is compiled by the respective authors based on publicly available information. We assume no responsibility whatsoever for any damage or disadvantage caused by actions taken based on such information. Unauthorized reproduction of articles, photos, charts, etc. is prohibited.
Copyright © 2021 LSMIP office / CM Plus Corporation

A Series of Articles

About the Author

Related Articles

No information is found.

Digital Health
U.S. eHealth Journal

Vol. 73 (Issued at 2022/09/27)

日本で医療用医薬品ネット販売を検討中と一部報道で囁かれているAmazonだが、米国ではプライマリケアプログラム「Amazon Care」向けの買収や提携を積極的に強化し、ポストコロナのハイブリッド型ケアの将来を模索している。また、公的保険制度のメディケアでは、保険償還の対象となった遠隔患者モニタリング(RPM)の利用拡大傾向が調査で明らかとなった。スタートアップ各社では、レイオフのニュースが相次いだ一方、第2四半期の決算発表を通じて、各社の次の展開が少しずつ見えてきた。

Most Popular

1

The First Part: Promoting Social Implementation of Genome Medicine with Information Technology, Xcoo

Dr. Shinpaku

2

LSMIP Editorial Office

3

The second part: “MyChart” One App for All Personal Health Records

Sakura Ishikawa M.D.

4

MSA Partners, LLC

5

The Second Part: iCARE, Creating the Health of Workers Around the World

Dr. Shinpaku

Press Room